Potential predictive markers of response to EGFR-targeted therapies in colorectal cancer.
about
Identification of Rho GTPase activating protein 6 isoform 1 variant as a new molecular marker in human colorectal tumors.Effective incorporation of biomarkers into phase II trialsA review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy.EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis.Epidermal growth factor receptor (EGFR) status and K-Ras mutations in colorectal cancer.Pharmacoepigenomics in colorectal cancer: a step forward in predicting prognosis and treatment response.Targeting the EGF receptor ectodomain in the context of cancer.KRAS genotyping of paraffin-embedded colorectal cancer tissue in routine diagnostics: comparison of methods and impact of histology.Mechanisms of resistance to anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer.Sensitive and specific KRAS somatic mutation analysis on whole-genome amplified DNA from archival tissues.MGMT methylation is associated primarily with the germline C>T SNP (rs16906252) in colorectal cancer and normal colonic mucosa.RHBDD2: a 5-fluorouracil responsive gene overexpressed in the advanced stages of colorectal cancer.Therapeutic efficiency of everolimus and lapatinib in xenograft model of human colorectal carcinoma with KRAS mutation.Are ADC values of readout-segmented echo-planar diffusion-weighted imaging (RESOLVE) correlated with pathological prognostic factors in rectal adenocarcinoma?
P2860
Q30952997-3D298729-4065-4774-B36E-5930E10B2667Q33870594-9C6D02F0-CB94-4055-93A0-F3B0792231ACQ35584153-CC46B83F-FB60-4FFF-8AF5-4382817C9E64Q37246657-25418722-C2D2-4A0E-95B3-E983BB24BADDQ37321897-460FE5BF-D0EE-4C08-9A87-CB2825FF5286Q37346216-CB09C0F6-E9B8-4814-8F0A-4785EB8EA609Q37600910-52A2D6E0-7CAA-47A7-99AF-9B7337EF50E7Q37653056-1DEF5464-D861-4F96-A63D-E266F3772D7AQ37707275-EE4EE5D0-60FB-4D78-8863-094307123321Q38418916-92621765-F5A5-4816-BDDD-6F44CE6793B9Q43280141-B2EA2D61-4948-44D3-A9DB-17FDE174A5A4Q45015381-73DDF198-8DA5-42C9-8D89-745B9BF99D99Q54520474-262B80C5-AF27-4CD4-8967-110F2000D88CQ55652172-3FDABD49-824E-475E-8C04-B66C0D59F162
P2860
Potential predictive markers of response to EGFR-targeted therapies in colorectal cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Potential predictive markers of response to EGFR-targeted therapies in colorectal cancer.
@en
Potential predictive markers of response to EGFR-targeted therapies in colorectal cancer.
@nl
type
label
Potential predictive markers of response to EGFR-targeted therapies in colorectal cancer.
@en
Potential predictive markers of response to EGFR-targeted therapies in colorectal cancer.
@nl
prefLabel
Potential predictive markers of response to EGFR-targeted therapies in colorectal cancer.
@en
Potential predictive markers of response to EGFR-targeted therapies in colorectal cancer.
@nl
P2093
P1476
Potential predictive markers of response to EGFR-targeted therapies in colorectal cancer.
@en
P2093
David Khayat
Gérard Milano
Jean Philippe Spano
Stéphane Vignot
P356
10.1016/J.CRITREVONC.2007.11.005
P577
2008-02-21T00:00:00Z